1. Berger, T. W., Kaul, S., Stricker, E. M. and Zigmond, M. J., 1985, Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats, Brain Res. 366: 354–358.
2. Bhargava, H. N., 1984, Effects of prolyl-leucyl-glycinamide and cyclo (leucylglycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol, Neuropharmacology 23: 439–444.
3. Bhargava, H. N., 1984, Enhanced striatal [3H] spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase, Life Sci. 34: 873–879.
4. Breese, G. R. and Traylor, T.D., 1972, Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine, Br. J. Pharmacol. 44: 210–222.
5. Breese, G. R., Baumeister, A. A., McCown, T. J., Emerick, S. G., Frye, G. D., Crotty, K and Mueller, R. A., 1984, Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine, J. Phannacol. Exp. Ther. 231: 343–354.